Vedolizumab for induction and maintenance of remission in Crohn's disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vedolizumab for induction and maintenance of remission in Crohn's disease

Published:2023-07-17 Issue:7 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hui Samuel¹,Sinopoulou Vassiliki²,Gordon Morris²,Aali Ghazaleh²³,Krishna Anuj⁴,Ding Nik Sheng⁵,Boyapati Ray K⁶

Affiliation:

1. Department of Gastroenterology, Monash Medical Centre; Melbourne Australia

2. School of Medicine; University of Central Lancashire; Preston UK

3. Institute for Health Informatics Research; University College London; London UK

4. Austin Health; Melbourne Australia

5. Department of Gastroenterology; St Vincent's Hospital; Melbourne Australia

6. Department of Gastroenterology; Monash Medical Centre; Melbourne Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference41 articles.

1. Treatment of active Crohn's disease with MLN0002, a humanized antibody to the alpha4beta7 integrin;Feagan;Clinical Gastroenterology and Hepatology,2008

2. Vedolizumab maintenance therapy for Crohn's disease: results of GEMINI II, a randomized, placebo-controlled, double-blind, multicenter phase 3 trial;Hanauer;American Journal of Gastroenterology,2012

3. Vedolizumab induction therapy for Crohn's disease: results of GEMINI II, a randomized, placebo-controlled, double-blind, multicenter phase 3 trial;Sandborn;American Journal of Gastroenterology,2012

4. Vedolizumab as induction and maintenance therapy for Crohn's disease;Sandborn;New England Journal of Medicine,2013

5. Vedolizumab as induction and maintenance therapy for Crohn's disease;Sandborn;New England Journal of Medicine,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory Complications in Chronic Granulomatous Disease;Journal of Clinical Medicine;2024-02-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3